Pfizer Amgen: That Pfizer’s Seagen Bet Could Lead
Pfizer’s Seagen integration is starting to pay off, signaling a shift in oncology bets as Amgen pursues a rebuild thr...
A quick look at the safest stablecoins for newcomers, highlighting factors like reserve transparency and market liquidity.
19,229 articlesPfizer’s Seagen integration is starting to pay off, signaling a shift in oncology bets as Amgen pursues a rebuild thr...
A 67-year-old single retiree with $920,000 could extend retirement beyond typical horizons if Social Security COLA re...
BAI has surged 61% over the trailing year but faced a midweek pullback. Here are two signals that will determine whet...
A once-niche software play may be quietly building a full AI-driven financial platform. This software stock could del...
Zillow, MRED and Compass exchanged new briefs after a two-day hearing on Chicagoland data access, intensifying an ant...
Discover how NVIDIA stands at the center of the AI revolution, what to watch in its business, and how to assess the i...
Palantir trades sales. Here's a clear-eyed view of why the market pays up for this AI-driven data platform, plus acti...
XRP failed to sustain a move above $1.40 this week, opening the door to downside risk. Here are the latest ripple (xr...
JPMorgan Chase's CEO says the public frustration with wealth concentration is real, and calls for policy and corporat...
Nvidia's upcoming earnings could be the turning point for AI stocks. This article breaks down what to watch, possible...
A one-time lottery windfall can trigger IRMAA surcharges, lifting Medicare premiums for the following year. Here's ho...
Mizuho ups UnitedHealth's price target to $440, citing easing medical loss ratio pressures and a turning Medicare Adv...